Author

C. R. Cogle

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Riva· 2 shared A. H. Elsayed· 1 shared A. J. Winer· 1 shared A. Meacham· 1 shared B. K. Law· 1 shared C. Gunaratne· 1 shared C. M. Berntsen· 1 shared C. Taragjini· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Riva

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Heterogeneous Nuclear Ribonucleoprotein C is an Indispensable Target in Acute Myeloid Leukemia

V. Vijay, A. Meacham, L. M. Katzell, A. J. Winer, J. Terrell, V. L. Archibald, L. T. Vaughn, L. Drusbosky, E. Thach, G. Welmaker, M. Giulianotti, S. Brothers, E. Beurel, J. L. Bubenik, M. Swanson, , C. R. Cogle

This study identifies HNRNPC as a critical therapeutic target in AML by showing its role in regulating Myc-Max activity through alternative splicing.

bioRxiv · Oct 2, 2023 · PreprintCancer Biology

DNMT3A harboring leukemia-associated mutations directs sensitivity to DNA damage at replication forks

K. Venugopal, P. Nowialis, Y. Feng, D. E. Shabashvili, C. M. Berntsen, K. I. Krajcik, C. Taragjini, Z. Zaroogian, H. L. Casellas-Roman, L. M. Posada, C. Gunaratne, J. Li, D. Dupere-Richer, R. L. Bennett, S. Pondugula, , O. A. Guryanova

This study shows that DNMT3A mutations impair replication fork recovery, leading to DNA damage and sensitivity to nucleoside analogs like cytarabine.

bioRxiv · May 28, 2021Cancer Biology